Exploring 5-MeO-DMT as a pharmacological model for deconstructed consciousness
Status PubMed-not-MEDLINE Language English Country Great Britain, England Media electronic-ecollection
Document type Journal Article
PubMed
40260121
PubMed Central
PMC12010161
DOI
10.1093/nc/niaf007
PII: niaf007
Knihovny.cz E-resources
- Keywords
- EEG, awareness, neurophenomenology, psychedelic, self, serotonin,
- Publication type
- Journal Article MeSH
5-MeO-DMT is a short-acting psychedelic that is anecdotally reported to induce a radical disruption of the self and a paradoxical quality of aroused, waking awareness that is nevertheless devoid of any specific perceptual contents. Here, we conducted an exploratory observational study of the phenomenological and neuronal effects of this compound. We collected micro-phenomenological interviews, psychometric questionnaires, and electroencephalography (EEG) in naturalistic ceremonial settings where 5-MeO-DMT was ingested. Results revealed that the 5-MeO-DMT experience followed a dynamic progression that-only in the most extreme cases-manifested as a complete absence of self-experience and other phenomenal content with preserved awareness. Furthermore, visual imagery, bodily self-disruption, narrative self-disruption, and reduced phenomenal distinctions occurred in a variable fashion. EEG analyses revealed the 5-MeO-DMT experience was characterised by (global) alpha and (posterior) beta power reductions, implying a mode of brain functioning where top-down models are inhibited. Our preliminary phenomenological findings confirm the potential utility of 5-MeO-DMT as a pharmacological model for deconstructed consciousness while noting the limitations of employing retrospective questionnaires for this purpose. Considering the exploratory nature of this study and its limitations inherent to its naturalistic nature, further research employing real-time experience sampling and phenomenologically trained participants in controlled environments could expand our findings to meaningfully inform the potential of this tool for the scientific study of consciousness.
3rd Faculty of Medicine Charles University Prague Prague 100 00 Czech Republic
Department of Experimental Psychology University College London London WC1H 0AP UK
Department of Neurology University of California San Francisco San Francisco 94143 USA
Fundació Sant Joan de Déu Barcelona 08014 Spain
Medical Anthropology Research Center Universitat Rovira i Virgili Tarragona 43005 Spain
Parc Sanitari Sant Joan de Dèu Barcelona 08830 Spain
Psychedelic Research Center National Institute of Mental Health Klecany 250 67 Czech Republic
See more in PubMed
Acosta-Urquidi J. EEG studies of the acute effects of the visionary tryptamine DMT. In: Columbus AM (ed.),
Blackburne G, McAlpine RG, Fabus M et al. Complex slow waves radically reorganise human brain dynamics under 5-MeO-DMT. 2024. doi: 10.1101/2024.10.04.616717 DOI
Carhart-Harris RL, Friston KJ. REBUS and the anarchic brain: toward a unified model of the brain action of psychedelics. PubMed DOI PMC
Carhart-Harris RL, Leech R, Hellyer PJ et al. The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs. PubMed DOI PMC
Clarke V, Braun V. Thematic analysis. DOI
Ermakova AO, Dunbar F, Rucker J et al. A narrative synthesis of research with 5-MeO-DMT. PubMed DOI PMC
Erritzoe D, Timmermann C, Godfrey K et al. Exploring mechanisms of psychedelic action using neuroimaging. DOI
Mediano PA, Rosas FE, Luppi AI et al. Spectrally and temporally resolved estimation of neural signal diversity. DOI
Metzinger T. Minimal phenomenal experience meditation, tonic alertness, and the phenomenology of.
Metzner R. The Toad and the Jaguar: A Field Report of Underground Research on a Visionary Medicine Bufo alvarius and 5-methoxy-dimethyltryptamine. Berkeley, CA: Regent Press, 2013.
Nichols DE. Psychedelics. PubMed PMC
Ona G, Sampedro F, Romero S et al. The kappa opioid receptor and the sleep of reason: cortico-subcortical imbalance following salvinorin-A. PubMed DOI PMC
Oostenveld R, Fries P, Maris E et al. Fieldtrip: open source software for advanced analysis of MEG, EEG, and invasive electrophysiological data. PubMed DOI PMC
Pallavicini C, Cavanna F, Zamberlan F et al. Neural and subjective effects of inhaled N,N-dimethyltryptamine in natural settings. PubMed DOI
Petitmengin C. Describing one’s subjective experience in the second person: an interview method for the science of consciousness. DOI
Petitmengin C, Remillieux A, Cahour B et al. A gap in Nisbett and Wilson’s findings? A first-person access to our cognitive processes. PubMed DOI
Petitmengin C, Remillieux A, Valenzuela-Moguillansky C. Discovering the structures of lived experience: towards a micro-phenomenological analysis method. DOI
Roseman L, Nutt DJ, Carhart-Harris RL. Quality of acute psychedelic experience predicts therapeutic efficacy of psilocybin for treatment-resistant depression. PubMed DOI PMC
Studerus E, Gamma A, Vollenweider FX. Psychometric evaluation of the altered states of consciousness rating scale (OAV). PubMed DOI PMC
Timmermann C. The Effects of DMT and Associated Psychedelics on the Human Mind and Brain. London: Imperial College London, 2020.
Timmermann C, Bauer PR, Gosseries O et al. A neurophenomenological approach to non-ordinary states of consciousness: hypnosis, meditation, and psychedelics. PubMed DOI
Timmermann C, Roseman L, Haridas S et al. Human brain effects of DMT assessed via EEG-fMRI. PubMed DOI PMC
Timmermann C, Roseman L, Schartner M et al. Neural correlates of the DMT experience assessed with multivariate EEG. PubMed DOI PMC
Timmermann C, Watts R, and Dupuis D. Towards psychedelic apprenticeship: developing a gentle touch for the mediation and validation of psychedelic-induced insights and revelations. PubMed DOI PMC
Trautwein FM, Schweitzer Y, Dor-Ziderman Y et al. Suspending the embodied self in meditation attenuates beta oscillations in the posterior medial cortex. PubMed DOI PMC
Uthaug MV, Lancelotta R, Szabo A et al. Prospective examination of synthetic 5-methoxy-N,N-dimethyltryptamine inhalation: effects on salivary IL-6, cortisol levels, affect, and non-judgment. PubMed DOI PMC
Yeshurun Y, Nguyen M, Hasson U. The default mode network: where the idiosyncratic self meets the shared social world. PubMed DOI PMC